Clinical trials
Completed Phase 3 Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Novartis Pharmaceuticals | 2 |
| Biogen | 1 |
| Fudan University | 1 |
| Janssen Research & Development, LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Shanghai Henlius Biotech | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 10 |
| Lymphoma | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Burkitt Lymphoma | 1 |
| Cardiotoxicity | 1 |
| Hematologic Neoplasms | 1 |
| Lymphoma, Large-Cell, Immunoblastic | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.